Table 7 Confirmation papers for the first new interaction predicted in 2005 for each subnetwork.
From: Can the vector space model be used to identify biological entity activities?
Subnetwork | Dimensional Space | First Interaction | Confirmation Papers |
|---|---|---|---|
1 | disease × drug | impotence divalproex | |
2 | disease × gene | acquired immunodeficiency syndrome transforming growth factor, beta 1 | |
3 | disease × target | arrhythmia cyclic-gmp phosphodiesterase | [60] |
4 | drug × gene | ciclosporin androgen receptor | |
5 | drug × target | verapamil cyclooxygenase 2 | none |
6 | gene × target | androgen receptor adrenaline | [9] |
7 | disease × drug × gene | gout hydrochlorothiazide endothelin 1 | none |
8 | disease × drug × target | alzheimer’s disease aspirin adrenaline | none |
9 | disease × gene × target | parkinson’s disease apolipoprotein e choline acetylase | none |
10 | drug × gene × target | acarbose apolipoprotein a-1 lymphotoxin | none |
11 | disease × drug × gene × target | breast cancer tamoxifen ppar-gamma hmg-coa reductase | none |